Report Content

Chapter 1. Methodology

1.1. Methodology

1.2. Market definitions

1.3. Forecast parameters

1.4. Data Sources

1.4.1. Secondary

1.4.1.1. Paid sources

1.4.1.2. Unpaid sources

1.4.2. Primary

Chapter 2. Executive Summary

2.1. Digital genome industry 360⁰ synopsis, 2014 - 2025 (USD Million)

2.1.1. Business trends

2.1.2. Product trends

2.1.3. Application trends

2.1.4. End-use trends

2.1.5. Regional trends

Chapter 3. Digital Genome Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Successful completion of the human genome project

3.3.1.2. Growing funding for genomics

3.3.1.3. Developments in biotechnology

3.3.1.4. Increasing demand for personalized medicines

3.3.1.5. Reduced cost and high speed of DNA sequencing

3.3.1.6. Entry of new players and start-ups in developing economies

3.3.1.7. Rising prevalence of chronic diseases

3.3.2. Industry pitfalls & challenges

3.3.2.1. Lack of experienced professionals

3.3.2.2. Concerns pertaining to security and confidentiality of patient data

3.4. Growth potential analysis

3.4.1. By product

3.4.2. By application

3.4.3. By end-use

3.5. Regulatory landscape

3.6. Reimbursement scenario

3.7. Industry Ecosystem

3.8. Technology landscape

3.9. Company Share analysis

3.10. Pricing Analysis

3.10.1. Porter's analysis

3.11. Competitive landscape, 2018

3.11.1. Strategy dashboard

3.12. PESTEL analysis

Chapter 4. Digital Genome Market, By Product

4.1. Digital genome market share by product, 2018 & 2025

4.2. Sequencing & analyzer instruments

4.2.1. Market size, 2014 – 2025 (USD Million)

4.3. DNA/RNA analysis kits

4.3.1. Market size, 2014 – 2025 (USD Million)

4.4. Sequencing chips

4.4.1. Market size, 2014 – 2025 (USD Million)

4.5. Sequencing & analysis software

4.5.1. Market size, 2014 – 2025 (USD Million)

4.6. Sample preparation instruments

4.6.1. Market size, 2014 – 2025 (USD Million)

Chapter 5. Digital Genome Market, By Application

5.1. Digital genome market share by application, 2018 & 2025

5.2. Microbiology

5.2.1. Market size, 2014 – 2025 (USD Million)

5.2.2. Biological

5.2.2.1. Market size, 2014 – 2025 (USD Million)

5.2.3. Clinical

5.2.3.1. Market size, 2014 – 2025 (USD Million)

5.2.4. Industrial

5.2.4.1. Market size, 2014 – 2025 (USD Million)

5.3. Reproductive & genetic

5.3.1. Market size, 2014 – 2025 (USD Million)

5.4. Transplantation

5.4.1. Market size, 2014 – 2025 (USD Million)

5.5. Livestock and agriculture

5.5.1. Market size, 2014 – 2025 (USD Million)

5.6. Forensics

5.6.1. Market size, 2014 – 2025 (USD Million)

5.7. Research and development

5.7.1. Market size, 2014 – 2025 (USD Million)

Chapter 6. Digital Genome Market, By End-use

6.1. Digital genome market share by application, 2018 & 2025

6.2. Diagnostics & forensic labs

6.2.1. Market size, 2014 – 2025 (USD Million)

6.3. Academic Research institutes

6.3.1. Market size, 2014 – 2025 (USD Million)

6.4. Hospitals

6.4.1. Market size, 2014 – 2025 (USD Million)

6.5. Bio-pharmaceutical companies

6.5.1. Market size, 2014 – 2025 (USD Million)

Chapter 7. Digital Genome Market, By Region

7.1. Key regional trends

7.2. North America

7.2.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

7.2.2. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.2.3. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.2.3.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.2.4. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.2.5. U.S.

7.2.5.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.2.5.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.2.5.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.2.5.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.2.6. Canada

7.2.6.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.2.6.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.2.6.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.2.6.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.3. Europe

7.3.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

7.3.2. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.3.3. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.3.3.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.3.4. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.3.5. Germany

7.3.5.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.3.5.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.3.5.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.3.5.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.3.6. UK

7.3.6.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.3.6.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.3.6.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.3.6.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.3.7. France

7.3.7.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.3.7.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.3.7.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.3.7.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.3.8. Italy

7.3.8.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.3.8.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.3.8.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.3.8.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.3.9. Spain

7.3.9.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.3.9.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.3.9.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.3.9.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.4. Asia Pacific

7.4.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

7.4.2. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.4.3. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.4.3.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.4.4. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.4.5. China

7.4.5.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.4.5.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.4.5.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.4.5.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.4.6. Japan

7.4.6.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.4.6.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.4.6.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.4.6.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.4.7. India

7.4.7.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.4.7.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.4.7.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.4.7.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.4.8. Australia

7.4.8.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.4.8.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.4.8.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.4.8.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.5. Latin America

7.5.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

7.5.2. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.5.3. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.5.3.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.5.4. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.5.5. Brazil

7.5.5.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.5.5.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.5.5.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.5.5.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.5.6. Mexico

7.5.6.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.5.6.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.5.6.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.5.6.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.5.7. Argentina

7.5.7.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.5.7.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.5.7.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.5.7.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.6. MEA

7.6.1. Market estimates and forecast, by country, 2014 – 2025 (USD Million)

7.6.2. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.6.3. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.6.3.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.6.4. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.6.5. South Africa

7.6.5.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.6.5.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.6.5.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.6.5.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

7.6.6. Saudi Arabia

7.6.6.1. Market estimates and forecast, by product, 2014 – 2025 (USD Million)

7.6.6.2. Market estimates and forecast, by application, 2014 – 2025 (USD Million)

7.6.6.2.1. Market estimates and forecast, by microbiology, 2014 – 2025 (USD Million)

7.6.6.3. Market estimates and forecast, by end-use, 2014 – 2025 (USD Million)

Chapter 8. Company Profiles

8.1. Agilent Technologies Inc.

8.1.1. Business Overview

8.1.2. Financial data

8.1.3. Product landscape

8.1.4. Strategic outlook

8.1.5. SWOT analysis

8.2. bioMerieux

8.2.1. Business Overview

8.2.2. Financial data

8.2.3. Product landscape

8.2.4. Strategic outlook

8.2.5. SWOT analysis

8.3. Becton, Dickinson and Company

8.3.1. Business Overview

8.3.2. Financial data

8.3.3. Product landscape

8.3.4. Strategic outlook

8.3.5. SWOT analysis

8.4. F. Hoffmann-La Roche Ltd.

8.4.1. Business overview

8.4.2. Financial data

8.4.3. Product landscape

8.4.4. Strategic outlook

8.4.5. SWOT analysis

8.5. GE Healthcare

8.5.1. Business overview

8.5.2. Financial data

8.5.3. Product landscape

8.5.4. Strategic outlook

8.5.5. SWOT analysis

8.6. Genomic Health, Inc.

8.6.1. Business overview

8.6.2. Financial data

8.6.3. Product landscape

8.6.4. Strategic outlook

8.6.5. SWOT analysis

8.7. GenMark Diagnostics, Inc.

8.7.1. Business overview

8.7.2. Financial data

8.7.3. Product landscape

8.7.4. Strategic outlook

8.7.5. SWOT analysis

8.8. Illumina

8.8.1. Business overview

8.8.2. Financial data

8.8.3. Product landscape

8.8.4. Strategic outlook

8.8.5. SWOT analysis

8.9. Inscripta Inc.

8.9.1. Business overview

8.9.2. Financial data

8.9.3. Product landscape

8.9.4. Strategic outlook

8.9.5. SWOT analysis

8.10. NanoString Technologies, Inc.

8.10.1. Business overview

8.10.2. Financial data

8.10.3. Product landscape

8.10.4. Strategic outlook

8.10.5. SWOT analysis

8.11. Pacific Bioscience

8.11.1. Business overview

8.11.2. Financial data

8.11.3. Product landscape

8.11.4. Strategic outlook

8.11.5. SWOT analysis

8.12. PerkinElmer Inc.

8.12.1. Business overview

8.12.2. Financial data

8.12.3. Product landscape

8.12.4. Strategic outlook

8.12.5. SWOT analysis

8.13. Quest Diagnostics

8.13.1. Business overview

8.13.2. Financial data

8.13.3. Product landscape

8.13.4. Strategic outlook

8.13.5. SWOT analysis

8.14. Regeneron Pharmaceuticals, Inc.

8.14.1. Business Overview

8.14.2. Financial data

8.14.3. Product landscape

8.14.4. Strategic outlook

8.14.5. SWOT analysis

8.15. Qiagen

8.15.1. Business Overview

8.15.2. Financial data

8.15.3. Product landscape

8.15.4. Strategic outlook

8.15.5. SWOT analysis

8.16. Thermo Fisher Scientific

8.16.1. Business overview

8.16.2. Financial data

8.16.3. Product landscape

8.16.4. Strategic outlook

8.16.5. SWOT analysis

Digital Genome Market

Inquiry Before Buying